β-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation

被引:122
作者
Ahn, Seungkirl
Kim, Jihee
Hara, Makoto R.
Ren, Xiu-Rong
Lefkowitz, Robert J. [1 ,2 ,3 ]
机构
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA
基金
美国国家卫生研究院;
关键词
PROTEIN-COUPLED RECEPTOR; RIBOSOMAL S6 KINASE; BETA-ARRESTIN; ANGIOTENSIN-II; CELL-SURVIVAL; AKT PHOSPHORYLATION; ERK1/2; ACTIVATION; DEATH; MITOCHONDRIA; TRANSCRIPTION;
D O I
10.1074/jbc.M808463200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
beta-Arrestins, originally discovered as terminators of G protein-coupled receptor signaling, have more recently been appreciated to also function as signal transducers in their own right, although the consequences for cellular physiology have not been well understood. Here we demonstrate that beta-arrestin-2 mediates anti-apoptotic cytoprotective signaling stimulated by a typical 7-transmembrane receptor the angiotensin ATII 1A receptor, expressed endogenously in rat vascular smooth muscle cells or by transfection in HEK-293 cells. Receptor stimulation leads to concerted activation of two pathways, ERK/p90RSK and PI3K/AKT, which converge to phosphorylate and inactivate the pro-apoptotic protein BAD. Anti-apoptotic effects as well as pathway activities can be stimulated by an angiotensin analog (SII), which has been previously shown to activate beta-arrestin but not G protein-dependent signaling, and are abrogated by beta-arrestin-2 small interfering RNA. These findings establish a key role for beta-arrestin-2 in mediating cellular cytoprotective functions by a 7-transmembrane receptor and define the biochemical pathways involved.
引用
收藏
页码:8846 / 8856
页数:11
相关论文
共 50 条
  • [1] The Bcl-2 apoptotic switch in cancer development and therapy
    Adams, J. M.
    Cory, S.
    [J]. ONCOGENE, 2007, 26 (09) : 1324 - 1337
  • [2] Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by β-arrestins 1 and 2
    Ahn, S
    Wei, HJ
    Garrison, TR
    Lefkowitz, RJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (09) : 7807 - 7811
  • [3] Differential kinetic and spatial patterns of β-arrestin and G protein-mediated ERK activation by the angiotensin II receptor
    Ahn, SK
    Shenoy, SK
    Wei, HJ
    Lefkowitz, RJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (34) : 35518 - 35525
  • [4] Identification of new genes differentially expressed in coronary artery disease by expression profiling
    Archacki, SR
    Angheloiu, G
    Tian, XL
    Tan, FL
    DiPaola, N
    Shen, GQ
    Moravec, C
    Ellis, S
    Topol, EJ
    Wang, Q
    [J]. PHYSIOLOGICAL GENOMICS, 2003, 15 (01) : 65 - 74
  • [5] ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882
  • [6] Survival signaling goes BAD
    Bergmann, A
    [J]. DEVELOPMENTAL CELL, 2002, 3 (05) : 607 - 608
  • [7] Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms
    Bonni, A
    Brunet, A
    West, AE
    Datta, SR
    Takasu, MA
    Greenberg, ME
    [J]. SCIENCE, 1999, 286 (5443) : 1358 - 1362
  • [8] Alternative, nonapoptotic programmed cell death -: Mediation by arrestin 2, ERK2, AND Nur77
    Castro-Obregón, S
    Rao, RV
    del Rio, G
    Chen, SF
    Poksay, KS
    Rabizadeh, S
    Vesce, S
    Zhang, XK
    Swanson, RA
    Bredesen, DE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (17) : 17543 - 17553
  • [9] 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation
    Datta, SR
    Katsov, A
    Hu, L
    Petros, A
    Fesik, SW
    Yaffe, MB
    Greenberg, ME
    [J]. MOLECULAR CELL, 2000, 6 (01) : 41 - 51
  • [10] Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis
    Datta, SR
    Ranger, AM
    Lin, MZ
    Sturgill, JF
    Ma, YC
    Cowan, CW
    Dikkes, P
    Korsmeyer, SJ
    Greenberg, ME
    [J]. DEVELOPMENTAL CELL, 2002, 3 (05) : 631 - 643